v3.26.1
Agreements and Transactions with VIE’s
6 Months Ended
Jun. 30, 2026
Agreements And Transactions With Vies  
Agreements and Transactions with VIE’s

Note 5 – Agreements and Transactions with VIE’s

 

The Company sells INVOcells to its VIEs and anticipates continuing to do so in the ordinary course of business. All intercompany transactions with consolidated entities are eliminated in the Company’s consolidated financial statements.

 

The following table summarizes the Company’s transactions with VIEs:

 

   2026   2025   2026   2025 
  

Three Months Ended

June 30,

  

Six Months Ended

June 30,

 
   2026   2025   2026   2025 
Consolidated VIE’s                    
INVOcell revenue  $2,376   $9,000   $14,376   $13,500 
Unconsolidated VIEs                    
INVOcell revenue  $-   $-   $3,000   $3,000